Johnson & Johnson has announced plans to expand its medical devises and diagnostics business with more than 30 new products, new business models and by focusing on fast-growing emerging markets.

DePuy Synthes Companies, J&J’s orthopaedics business with an office in West Chester, has announced three new products:

• The GLOBAL® UNITE® Anatomic Shoulder System (above) is part of a larger platform enabling surgeons to repair or replace shoulders in a simpler and more efficient manner while optimizing the patient’s range of motion.

• The CORAIL® Revision Hip System is the first tapered wedge revision system in the U.S. and is engineered to reduce the operating room footprint while delivering patient benefits through its bone-preserving design.

• The TRUMATCH® Resection Guide for the recently launched ATTUNE® Rotating Platform Knee. TRUMATCH® Personalized Solutions provides patient-specific instruments developed from a CT scan to reduce surgical steps and customize the procedure to each patient.

Johnson & Johnson’s medical devices and diagnostics business had $28.5 billion in sales in 2013. The company’s MD&D businesses compete in approximately 30 percent of the estimated $370 billion global market, and many of the key markets in which these businesses compete are projected to grow faster than the overall market over the next five years.

“Our businesses are uniquely positioned to continue helping patients while also leading the industry by

capitalizing on our breadth, depth and scale,” said Dominic J. Caruso, vice president of finance and chief financial officer for Johnson & Johnson. “We are developing innovative products and working with health care systems on customer-focused solutions to ultimately improve outcomes for patients.”

J&J’s global surgery business is also delivering a pipeline of innovative products that serve large, unmet health care needs including the EVARREST Fibrin Sealant Patch to stop bleeding.

A full report to investors is at: www.investor.jnj.com.

Links: www.investor.jnj.com